Early Registration Discount in Effect through September 7
Jackson/Wall,
New Jersey (Sharewellnewswire.com) September 6, 2012 - The Lyme Disease
Association (LDA) and Columbia University College of Physicians and
Surgeons announce their jointly sponsored 13th annual national
conference, entitled “Lyme and Tick-Borne Diseases: Microbial
Persistence & Tick-Borne Diseases New Scientific & Clinical
Directions.” Designed for health care providers and offering 13.0 AMA
PRA Category 1 Credits™ to CME registrants, the conference is Sept. 29,
30, 2012, Hyatt Bellevue, Philadelphia, PA. The public is also invited
to register. Lyme Disease Association Conference Info
Twenty
faculty members including two European presenters, are led by the
conference Course Co-Directors Stephen Barthold, DVM, PhD (University
of California, Davis), a member of the Institute of Medicine and a
pioneer in the study of Borrelia in the Mouse model, and Brian Fallon,
MD, MPH, Director of the Columbia Lyme & Tick-Borne Diseases
Research Center in New York, well-known for research on neurologic and
neuropsychiatric Lyme disease. The conference presenters will provide
their expertise covering a broad range of research and clinical topics.
A
focus of the meeting is to explore the significance of recent findings
in the monkey and mouse model that demonstrate the persistence of
Borrelia burdorferi (Bb) infection despite antibiotic treatment. A
presentation from the Chief of the Bacterial Diseases Branch of the
Centers for Disease Control & Prevention (CDC), Division of
Vector-Borne Infectious Diseases, will describe recent trends in
tick-borne diseases, including information about the newly described
phlebovirus identified in 2 patients after tick exposure in Missouri.
Other topics include: diagnostic assays from Europe and the
implications of genomic differences in Bb strains in the United States;
what we know about chronic inflammation in Lyme disease based on the
mouse model; treatment approaches including in vitro sensitivity
studies of Bb to antimicrobials and the role of nutrition in recovery;
newly studied reservoir targeted vaccines; a review of how Bb causes
disease and its implications for the pregnant woman; typical &
atypical neurologic presentations (including “Alice in Wonderland
Syndrome”); immunologic findings in early Lyme disease; long-term
follow-up studies of neurologic Lyme disease; how Bb compromise the
blood brain barrier; the significance of antiphospholipid antibodies in
patients with chronic symptoms; and an exploration of Lyme disease,
depression and suicide. Poster presentations will also be available.
Exhibitors will be on-site.
Lyme
disease is a serious multi-systemic infection, which can cause
arthritic, muscular-skeletal, cardiac, neurologic, ophthalmologic, and
psychiatric manifestations. The classic bull’s eye rash is not always
present, and testing may not be reliable, so an early clinical
diagnosis and appropriate treatment are needed to help to prevent Lyme
from becoming established.
ABOUT THE LDA: The
Lyme Disease Association (LDA) is partners with over 40 other
organizations nationwide, and LDA and affiliate Lyme Research Alliance
endowed the Columbia Lyme Research Center in New York in 2007, the only
Center to focus on chronic Lyme disease. LDA-funded research has been
published in 25 peer-reviewed journals to date. LDA has awarded over 81
research and 70 educational grants, provided 250 grants through its
LymeAid 4 Kids fund for uninsured children, has free doctor referrals
on its website, and provides free brochures available through online
order.
Borrelia burgdorferi (Lyme spirochete) expressing green flourescence protein in tissue of a mouse. Thanks to Stephen W. Barthold, DVM, PhD
Source: http://www.sharewellnewswire.com/scientific-conference-presents-latest-findings-in-lyme-disease-research-amp-clinical-developments-2701.htm/#ixzz25l9VrOq7
